AbbVie Inc.
NYSE:ABBV
200.47 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 54,318 | 58,054 | 56,197 | 45,804 | 33,266 | 32,753 | 28,216 | 25,638 | 22,859 | 19,960 | 18,790 | 18,380 | 17,443.951 | 15,638 | 14,214.196 |
| Cost of Revenue
| 8,780 | 17,414 | 17,446 | 15,387 | 7,439 | 7,718 | 7,040 | 5,833 | 4,500 | 4,426 | 4,581 | 4,508 | 4,639.393 | 4,293 | 4,056.39 |
| Gross Profit
| 45,538 | 40,640 | 38,751 | 30,417 | 25,827 | 25,035 | 21,176 | 19,805 | 18,359 | 15,534 | 14,209 | 13,872 | 12,804.558 | 11,345 | 10,157.806 |
| Gross Profit Ratio
| 0.838 | 0.7 | 0.69 | 0.664 | 0.776 | 0.764 | 0.75 | 0.772 | 0.803 | 0.778 | 0.756 | 0.755 | 0.734 | 0.725 | 0.715 |
| Reseach & Development Expenses
| 7,032 | 6,510 | 7,084 | 6,557 | 6,407 | 10,329 | 4,982 | 4,366 | 4,285 | 3,297 | 2,855 | 2,778 | 2,617.506 | 2,495 | 1,707.44 |
| General & Administrative Expenses
| 10,945 | 13,260 | 10,249 | 9,499 | 5,842 | 7,399 | 6,275 | 5,855 | 6,387 | 7,724 | 5,352 | 4,989 | 5,893.82 | 3,820 | 3,348.572 |
| Selling & Marketing Expenses
| 2,200 | 2,000 | 2,100 | 1,800 | 1,100 | 1,100 | 846 | 764 | 704 | 665 | 626 | 506 | 0 | 0 | 0 |
| SG&A
| 13,145 | 15,260 | 12,349 | 11,299 | 6,942 | 7,399 | 6,275 | 5,855 | 6,387 | 7,724 | 5,352 | 4,989 | 5,893.82 | 3,820 | 3,348.572 |
| Other Expenses
| -7,936 | 56 | 432 | -5,614 | -890 | -18 | -513 | -232 | -13 | 27 | 1 | 9 | 0 | 61 | 0 |
| Operating Expenses
| 28,113 | 21,826 | 19,865 | 17,856 | 12,459 | 18,228 | 11,257 | 10,221 | 10,672 | 11,771 | 8,207 | 7,767 | 8,511.326 | 6,315 | 5,056.012 |
| Operating Income
| 12,757 | 18,117 | 17,924 | 11,363 | 12,983 | 6,383 | 9,545 | 9,340 | 7,537 | 3,411 | 5,664 | 6,622 | 3,620.732 | 4,717 | 4,931.794 |
| Operating Income Ratio
| 0.235 | 0.312 | 0.319 | 0.248 | 0.39 | 0.195 | 0.338 | 0.364 | 0.33 | 0.171 | 0.301 | 0.36 | 0.208 | 0.302 | 0.347 |
| Total Other Income Expenses Net
| -6,507 | -4,640 | -4,935 | -7,965 | -4,557 | -1,186 | -1,818 | -1,456 | -892 | -1,042 | -332 | -897 | -624.705 | -222 | 848.523 |
| Income Before Tax
| 6,250 | 13,477 | 12,989 | 3,398 | 8,426 | 5,197 | 7,727 | 7,884 | 6,645 | 2,369 | 5,332 | 5,725 | 3,668.527 | 4,836 | 5,950.317 |
| Income Before Tax Ratio
| 0.115 | 0.232 | 0.231 | 0.074 | 0.253 | 0.159 | 0.274 | 0.308 | 0.291 | 0.119 | 0.284 | 0.311 | 0.21 | 0.309 | 0.419 |
| Income Tax Expense
| 1,377 | 1,632 | 1,440 | 1,224 | 544 | 490 | 2,418 | 1,931 | 1,501 | 595 | 1,204 | 450 | 235.399 | 658 | 1,313.802 |
| Net Income
| 4,863 | 11,836 | 11,542 | 4,616 | 7,882 | 5,687 | 5,309 | 5,953 | 5,144 | 1,774 | 4,128 | 5,275 | 3,433.128 | 4,178 | 4,636.515 |
| Net Income Ratio
| 0.09 | 0.204 | 0.205 | 0.101 | 0.237 | 0.174 | 0.188 | 0.232 | 0.225 | 0.089 | 0.22 | 0.287 | 0.197 | 0.267 | 0.326 |
| EPS
| 2.73 | 6.65 | 6.48 | 2.73 | 5.3 | 3.69 | 3.31 | 3.65 | 3.15 | 1.11 | 2.58 | 3.35 | 2.12 | 2.59 | 2.87 |
| EPS Diluted
| 2.72 | 6.63 | 6.45 | 2.72 | 5.28 | 3.68 | 3.3 | 3.63 | 3.13 | 1.1 | 2.56 | 3.35 | 2.11 | 2.57 | 2.85 |
| EBITDA
| 26,358 | 31,424 | 28,280 | 21,148 | 16,264 | 13,688 | 11,774 | 10,812 | 9,692 | 6,286 | 6,914 | 7,772 | 4,892.926 | 5,901 | 5,629.286 |
| EBITDA Ratio
| 0.333 | 0.458 | 0.471 | 0.152 | 0.415 | 0.249 | 0.393 | 0.412 | 0.366 | 0.21 | 0.349 | 0.379 | 0.28 | 0.377 | 0.396 |